GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Regional Analysis

To learn more about this report, request sample copy

North America has established itself as the dominant region in the global pharmaceutical intermediates market over the past few decades. North America is anticipated to have 38.9% of the market share in 2024. The presence of major pharmaceutical companies and an advanced healthcare infrastructure have contributed significantly to the growth of this industry in the region. Strong R&D capabilities along with continual innovations have enabled North American companies to introduce new drugs and medical technologies at a rapid pace. This, in turn, drives the demand for various pharmaceutical intermediates that are used extensively during the drug manufacturing process. Additionally, contract manufacturing has become a major business model for pharmaceutical companies in the region outsourcing the production of intermediates.

The Asia Pacific region is witnessing the fastest growth and is emerging as the new hotspot for pharmaceutical intermediates market. Rapid industrialization and investment in healthcare sectors across many Asia Pacific countries such as India, China, South Korea, and Australia have boosted the region's pharmaceutical output in recent years. Low manufacturing costs and availability of skilled labor are attracting major investments from pharmaceutical giants expanding outsourced manufacturing facilities in the region. India especially has transformed into a global hub for generic drug production leveraging its cost advantage along with a large talent pool of chemists and engineers. Chinese companies are also aggressively expanding by acquiring foreign intermediates manufacturers as well as investing heavily in R&D. With growing expertise in synthesis capabilities, APAC intermediates producers are increasingly catering to global markets from Japan to North America.